Home World News A Polygenic Risk Score Assessment Reveals More Screening Participants with Clinically Significant... World News A Polygenic Risk Score Assessment Reveals More Screening Participants with Clinically Significant Prostate Cancer Than Those Who Would Be Identified with PSA or MRI By Ogkologos - April 30, 2025 861 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the BARCODE1 study Source RELATED ARTICLESMORE FROM AUTHOR Can ctDNA guide treatment intensification in EGFR mutated non-small cell lung cancer? How to select adjuvant endocrine therapy for postmenopausal women with HR-positive early breast cancer? EMA Recommends Extension of Therapeutic Indications for Abiraterone Acetate MOST POPULAR Jaw Problems Linked to Bone-Modifying Drugs Not as Rare as Once... September 26, 2024 Mathew Knowles, Father Of Beyoncé, Fought And Beat Breast Cancer November 5, 2019 Pioneer in Autism Diagnosis And Treatment Dies At 97 September 21, 2021 Progress in Treating GI Cancers Through Molecular Testing: The 2021 Advance... February 2, 2021 Load more HOT NEWS EMA Recommends Extension of Therapeutic Indications for Nivolumab Stereotactic Radiosurgery Not Superior in Terms of Pain Response Compared with... Many Men with Penile Cancer Do Not Get Recommended Treatments, Study... Selumetinib Continues to Show Promise in Children with NF1
